Brought to you by 
Brainsway nets $25.6mm through IPO of ADSs on Nasdaq
01 May 2019
Executive Summary
In its second attempt to list on Nasdaq, Brainsway Ltd. (deep transcranial magnetic stimulation device (TMS) for psychiatric, neurological, and addiction disorders) netted $25.6mm through its initial public offering of 2.5mm American Depositary Shares (ADSs, with each representing two ordinary shares) at $11 (or $5.50/share). Earlier this month the company announced it planned to sell 2.5mm ADSs at $11.94 apiece, or $5.97/share.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Brainsway nets $25.6mm through IPO of ADSs on Nasdaq
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice